Table 1

Characteristics of 214 Ugandan HIV infected children analysed for vitamin B12 and folate by intervention group

Number (N)

MMS n (%)

'Standard of care' MV n (%)

p-value


Sex: Male

100

49 (49.0)

51 (51.0)

>0.99

Age less than 24 months

70

33 (47.1)

37 (52.9)

0.77

Mother as carer

146

73 (50.0)

73 (50.0)

0.56

On HAART

44

19 (43.2)

25 (56.8)

0.50

Routine CTX

193

93 (48.2)

100 (51.8)

0.82

Routine MV

144

68 (47.2)

76 (52.8)

0.66

WHZ < -2

28

14 (50.0)

14 (50.0)

>0.99

HAZ < -2

113

56 (49.6)

57 (50.4)

0.89

WHO stage 3 or 4

56

26 (46.4)

30 (53.6)

0.76

CD4+ T cells < 25%

114

50 (43.9)

64 (56.1)

0.20

Elevated CRP (> 6 g/dl)

67

33 (49.3)

34 (50.7)

0.42

Low haemoglobin (< 11 g/dl)

127

61 (48.0)

66 (52.0)

0.89

Low vitamin B12 (< 221 pmol/L)

60

29 (48.3)

31 (51.7)

0.96

Low folate (< 13.4 nmol/L)

62

25 (40.3)

37 (59.7)

0.13


MMS = multiple micronutrient supplementation

HAART = Highly active anti-retroviral therapy

CTX = Cotrimoxazole

MV = 'standard of care' multivitamins

WHZ = Weight for height z-score

HAZ = Height for age z-score

WHO = World Health Organisation

CD4+ = Cluster of differentiation 4

CRP = C-reactive protein

Ndeezi et al. Nutrition Journal 2011 10:56   doi:10.1186/1475-2891-10-56

Open Data